Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Clinical trial NCT00912392 · COMPLETED
Trial details
- NCT number
- NCT00912392
- Sponsor
- Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2012-12-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.